News

SCI offering skin cancer screenings May 20

Central Illinois residents are encouraged to register for a free skin cancer screening from 5 - 7 p.m., Tuesday, May 20, at Simmons Cancer Institute at SIU Medicine, 315 W. Carpenter St. in Springfield.
News

SCI offering skin cancer screenings May 20

Central Illinois residents are encouraged to register for a free skin cancer screening from 5 - 7 p.m., Tuesday, May 20, at Simmons Cancer Institute at SIU Medicine, 315 W. Carpenter St. in Springfield.
News

SIU Medicine first in U.S. to pilot new trauma care course

SIU School of Medicine will host the first use of the newest edition of the Advanced Trauma Life Support course in the United States on April 29–30. The Southern Illinois Trauma Center (SITC) at Springfield Memorial Hospital and the Memorial Learning Center are piloting the training.
News

SIU Medicine first in U.S. to pilot new trauma care course

SIU School of Medicine will host the first use of the newest edition of the Advanced Trauma Life Support course in the United States on April 29–30. The Southern Illinois Trauma Center (SITC) at Springfield Memorial Hospital and the Memorial Learning Center are piloting the training.
News

SIU Medicine first in U.S. to pilot new trauma care course

SIU School of Medicine will host the first use of the newest edition of the Advanced Trauma Life Support course in the United States on April 29–30. The Southern Illinois Trauma Center (SITC) at Springfield Memorial Hospital and the Memorial Learning Center are piloting the training.
News

SIU Medicine first in U.S. to pilot new trauma care course

SIU School of Medicine will host the first use of the newest edition of the Advanced Trauma Life Support course in the United States on April 29–30. The Southern Illinois Trauma Center (SITC) at Springfield Memorial Hospital and the Memorial Learning Center are piloting the training.
News

Support available for Chatham community

"In this time of profound grief, we remain committed to offer compassion, comfort, and resources to aid in healing the families, friends, and Chatham community," Dr. Kruse added.
Trial
Neurology

Renaissance 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

Active recruiting

To evaluate the efficacy of SPN-817 as a treatment for adult participants with focal onset seizures.

Subscribe to